Larry A. Scher
<span style="color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;">Dr. Scher has extensive clinical experience and expertise in hemodialysis access and strong clinical and academic interests in this area.</span><quillbot-extension-portal></quillbot-extension-portal>
<span style="color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;">Dr. Scher has authored or co-authored numerous peer-reviewed publications in all areas of vascular surgery. </span><span style="color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;"></span><quillbot-extension-portal></quillbot-extension-portal>
<p style="box-sizing:border-box;border:0px solid rgb(226, 232, 240);margin-bottom:0px;color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;">Larry A. Scher, MD, is an Attending Vascular Surgeon at Montefiore and Professor of Cardiothoracic and Vascular Surgery at Albert Einstein College of Medicine. He was previously Chief of the Division of Vascular Surgery at North Shore University Hospital. Dr. Scher has extensive clinical experience and expertise in hemodialysis access, and possesses strong clinical and academic interests in this area.</p><p style="box-sizing:border-box;border:0px solid rgb(226, 232, 240);margin-top:2rem;margin-bottom:0px;color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;">After graduating from the Medical College of Wisconsin, Dr. Scher completed his residency in general surgery at the Medical College of Virginia and his fellowship in vascular surgery at Newark Beth Israel Medical Center. He is board certified in vascular surgery. </p><p style="box-sizing:border-box;border:0px solid rgb(226, 232, 240);margin-top:2rem;margin-bottom:0px;color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;">Dr. Scher has authored or co-authored numerous peer-reviewed publications in all areas of vascular surgery. He has spoken at regional, national and international symposia, with a most recent focus on hemodialysis access and dialysis access steal syndrome. Dr. Scher is a Founding Member of the Vascular Access Society of the Americas, Past President of the New York Society for Vascular Surgery and Director of the Hemodialysis Access Session at the annual VEITHsymposium.</p>
Evelyn M. Rondinel
Lisa Morrow
Haleh Moazen
Beth N. McLellan
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Beth McLellan graduated with honors from Northwestern University and attended medical school at Wayne State University where she graduated with Alpha Omega Alpha honors. She completed an internship in Internal Medicine at Loyola University Health System and her Dermatology residency at Henry Ford Health System in Detroit where she also served as Chief Resident. She currently is a Professor in the Department of Medicine (Dermatology) and has served as Chief of the Division of Dermatology since 2020.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan specializes in complex medical Dermatology and has a special interest in Supportive Oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair, and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis as well as successful use of bacterial decolonization for prevention of radiation dermatitis. She has published numerous articles and textbook chapters related to Supportive Oncodermatology and is regularly invited to speak at Dermatology and Oncology conferences for physicians and patients including the annual meeting of the American Academy of Dermatology, ASCO, and Gilda's Club.</span></p>
<p class="MsoNormal" style="margin-bottom: 0in; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Playing an active role in the Dermatology Residency, Dr. McLellan is the director of resident research and regularly lectures residents and medical students. She has served as a mentor to many residents and students and directs a year-long Oncodermatology research fellowship for medical students taking a year off for research. Interested medical students can learn more about the fellowship here: https://www.einsteinmed.edu/departments/medicine/divisions/dermatology/…;
<div> </div>
<div> </div>
<div> </div>
<p> </p>
Chemotherapy Side Effects
Scalp Cooling
Dr. McLellan specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.
Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis
<p>Beth N. McLellan, MD, is Chief, Dermatology, Director, Supportive Oncodermatology and Professor, Dermatology at Montefiore Einstein. She specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</p><p>After earning her Doctor of Medicine at Wayne State University, Dr. McLellan completed an internship in internal medicine at Loyola University Health System and her dermatology residency at Henry Ford Health System where she also served as chief resident and initiated a supportive oncodermatology clinic. Dr. McLellan received additional oncodermatology training at Memorial Sloan Kettering Cancer Center and at the Institut Gustave Roussy in Paris, France.</p><p>Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis. Playing an active role in the Montefiore Einstein Dermatology Residency, Dr. McLellan is the Director of Resident Research and regularly lectures residents and medical students at both dermatology and oncology meetings. She has served as a mentor to many residents and students and directs a year long oncodermatology research fellowship for medical students taking a year off for research. Dr. McLellan has published numerous articles and textbook chapters related to supportive oncodermatology and is regularly invited to speak at dermatology and oncology conferences for physicians and patients, including the annual meeting of the American Academy of Dermatology, American Society of Clinical Oncology and Gilda's Club.</p><p>As part of her commitment to treating the whole patient, Dr. McLellan founded the New York Vitiligo Support Group. She has received awards from the Dermatology Foundation.</p>
Ranon E. Mann
As Program Director my clinical focus is patient care and resident education. My interests surround<br />complex medical dermatology.
Research focus on skin disorders affecting patients who are HIV positive.
Evan C. Lipsitz
<p>A vascular surgeon, Dr. Lipsitz' research interests include the treatment of thoracic and abdominal aortic aneurysms, accessing them via the affected vessels using what clinicians call endovascular techniques. He investigates the role of wireless pressure-sensor technology in association with such treatment, and he has evaluated the use of endovascular stent-graft technology in the treatment of traumatic lesions.</p>
<p> </p>
<p>Dr. Lipsitz' research also has focused on limb salvage and the treatment of lower extremity peripheral vascular disease (PVD), the obstruction of large arteries to the legs. In treating PVD, he has studied both open surgical and endovascular techniques. He helped to popularize subintimal angioplasty in the U.S. The technique opens a totally occluded blood vessel using a wire passed within the wall of the vessel but not within the occluded "true" lumen, or inner open space, of the vessel. Once the wire is in place, a balloon is used to open the pathway.</p>
<p> </p>
<p>Additionally, Dr. Lipsitz maintains an active interest in the non-invasive laboratory diagnosis of vascular disease. He studies carotid artery disease and stroke prevention, and has evaluated the role of cerebral protection during carotid artery angioplasty and stenting. Cerebral protection seeks to minimize trauma to the brain during surgery by employing drugs and techniques, including positioning and specialized monitoring.</p>
<p>Endovascular Thoracic and Abdominal Aortic Aneurysm repair, Aortic dissection, Carotid Artery Disease and Stroke prevention, Lower extremity peripheral arterial disease and limb salvage, Endovascular and open treatments for aneurysms and peripheral arterial disease</p>
<p>Dr Lipsitz’ research interest includes the treatment of thoracic and abdominal aneurysms with endovascular graft technology. He has been an investigator in clinical trials of numerous grafts and has evaluated the efficacy of wireless pressure sensors and endostaples as adjunctive therapies utilized with these grafts.</p><p>Dr. Lipsitz' research has also focused on limb salvage and the treatment of lower extremity peripheral vascular disease (PVD), the obstruction of large arteries to the legs. In treating PVD, he has studied both open surgical and endovascular techniques, including the use of various grafts, and stents. His work helped popularize the minimally invasive technique of subintimal angioplasty in the U.S.</p>
<p>Evan C. Lipsitz, MD, MBA, is Chief, Division of Vascular and Endovascular Surgery, Medical Director, Vascular Diagnostic Laboratory, and Professor, Cardiothoracic and Vascular Surgery at Montefiore Einstein. His clinical focus encompasses the full range of vascular treatments, including endovascular thoracic and abdominal aortic aneurysm repair, aortic dissection, carotid artery disease and stroke prevention, lower extremity peripheral arterial disease and limb salvage, endovascular and open treatments for aneurysms and peripheral arterial disease.</p><p>In 1990, Dr. Lipsitz received his Doctor of Medicine from Columbia University’s College of Physicians and Surgeons. He pursued postdoctoral training at Presbyterian Hospital, Columbia-Presbyterian Medical Center, completing his internship and residency in general surgery as well as an ECMO clinical and research fellowship. He later came to Montefiore Einstein, completing his vascular surgery fellowship in 1999. In 2017, Dr. Lipsitz received his Master of Business Administration from The Heller School for Social Policy and Management, Brandeis University.</p><p>Dr. Lipsitz's research focus includes the utilization of endovascular graft technology for treating thoracic and abdominal aneurysms. He has been an investigator in clinical trials of numerous grafts and has evaluated the efficacy of wireless pressure sensors and endostaples as adjunctive therapies utilized with these grafts. Dr. Lipsitz has also focused research on limb salvage and the treatment of lower extremity peripheral vascular disease (PVD). In treating PVD, he has studied both open surgical and endovascular techniques, including the use of various grafts and stents. His work has helped popularize the minimally invasive technique of subintimal angioplasty technique in the United States. He is also interested in healthcare policy and development, particularly in the area of quality metrics. Dr. Lipsitz has published more than 110 papers in scientific journals and over 40 book chapters. He also is a reviewer for several journals and is active in healthcare policy and management.</p><p>Dr. Lipsitz is board certified by the National Board of Medical Examiners and is a member of several professional societies including the Society for Vascular Ultrasound, the Vascular and Endovascular Surgery Society and the International Society of Endovascular Specialists. He has been named in <em>New York Magazine’s</em> “Best Doctors in New York” as well as Castle Connolly’s “Top Doctors: New York Metro Area” for several years.</p>
Daniel K. Levy
Tobi B. Klar
<span style="font-family:Calibri, sans-serif;font-size:16px;">Dr. Klar’s clinical expertise includes general dermatological procedures, as well as more complex procedures such as the treatment of psoriasis and inflammatory dermatoses with phototherapy, topical therapy and biologic therapy.</span>
<span style="font-family:Calibri, sans-serif;font-size:16px;">Dr. Klar’s research interests are in treatment options for acne, psoriasis and eczema.</span>
<p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Tobi Klar, MD, is an attending physician and Assistant Professor at Montefiore-Einstein. Dr. Klar’s clinical expertise includes general dermatological procedures, as well as more complex procedures such as the treatment of psoriasis and inflammatory dermatoses with phototherapy, topical therapy and biologic therapy. Dr. Klar also treats cancers of the skin including melanoma, basal cell carcinoma and squamous cell carcinoma.<span> </span>She has advanced training and extensive experience treating adults and children for general dermatological conditions, including rashes, acne, rosacea and eczema. She also performs skin cancer screenings and treats premalignant and malignant conditions.</span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">After earning her Doctor of Medicine at the State University of New York Downstate in 1981, Dr. Klar continued at the institution for her postdoctoral training, completing her Internal Medicine Internship in 1982, her Internal Medicine Residency in 1983 and her Dermatology Residency in 1986.</span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Dr. Klar’s research interests are in treatment options for acne, psoriasis and eczema. </span></p> <p><span style="font-size:12.0pt;font-family:'Calibri',sans-serif;">Dr. Klar is board certified and is a member of several professional associations including the Society for Clinical Vascular Surgery, the Society of Vascular Ultrasound and the Peripheral Vascular Surgery Society.</span></p>